Institute of Microbiology, Department of Biology, ETH Zurich, Zurich, Switzerland.
Biozentrum, University of Basel, Basel, Switzerland.
Nat Rev Microbiol. 2020 Sep;18(9):479-490. doi: 10.1038/s41579-020-0378-z. Epub 2020 May 27.
Antibiotic treatment failure is of growing concern. Genetically encoded resistance is key in driving this process. However, there is increasing evidence that bacterial antibiotic persistence, a non-genetically encoded and reversible loss of antibiotic susceptibility, contributes to treatment failure and emergence of resistant strains as well. In this Review, we discuss the evolutionary forces that may drive the selection for antibiotic persistence. We review how some aspects of antibiotic persistence have been directly selected for whereas others result from indirect selection in disparate ecological contexts. We then discuss the consequences of antibiotic persistence on pathogen evolution. Persisters can facilitate the evolution of antibiotic resistance and virulence. Finally, we propose practical means to prevent persister formation and how this may help to slow down the evolution of virulence and resistance in pathogens.
抗生素治疗失败的问题日益受到关注。基因编码耐药性是导致这一问题的关键。然而,越来越多的证据表明,细菌对抗生素的持续存在,即非基因编码且可逆转的抗生素敏感性丧失,也会导致治疗失败和耐药菌株的出现。在这篇综述中,我们讨论了可能导致抗生素持续存在选择的进化力量。我们回顾了抗生素持续存在的某些方面是如何直接选择的,而其他方面则是在不同的生态环境中通过间接选择产生的。然后,我们讨论了抗生素持续存在对病原体进化的后果。持久性细菌可促进抗生素耐药性和毒力的进化。最后,我们提出了预防持久性细菌形成的实用方法,以及这如何有助于减缓病原体毒力和耐药性的进化。